Covered recipient · General Payments record
TARUN RAI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,707.82
- Reported across 128 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $630.36 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $374.22 | 20 |
| Madrigal Pharmaceuticals | $47.56 | 2 |
| Gilead Sciences, Inc. | $44.83 | 2 |
| QOL Medical, LLC | $41.35 | 2 |
| Janssen Biotech, Inc. | $33.90 | 2 |
| Regeneron Healthcare Solutions, Inc. | $21.29 | 1 |
| PFIZER INC. | $19.14 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.14 | 1 |
| Lilly USA, LLC | $16.25 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $13.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.88 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353770 | CMS |
| ABBVIE INC. | $22.80 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353774 | CMS |
| ABBVIE INC. | $13.10 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353778 | CMS |
| ABBVIE INC. | $8.40 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353782 | CMS |
| ABBVIE INC. | $13.17 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353785 | CMS |
| ABBVIE INC. | $23.53 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353790 | CMS |
| ABBVIE INC. | $21.82 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353794 | CMS |
| ABBVIE INC. | $15.46 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353798 | CMS |
| ABBVIE INC. | $17.05 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353802 | CMS |
| ABBVIE INC. | $20.73 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353805 | CMS |
| ABBVIE INC. | $19.33 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353809 | CMS |
| ABBVIE INC. | $24.79 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353814 | CMS |
| ABBVIE INC. | $21.45 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353818 | CMS |
| ABBVIE INC. | $26.05 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353822 | CMS |
| ABBVIE INC. | $15.97 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353826 | CMS |
| ABBVIE INC. | $18.33 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353830 | CMS |
| ABBVIE INC. | $15.09 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353834 | CMS |
| ABBVIE INC. | $16.93 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353838 | CMS |
| ABBVIE INC. | $19.18 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353842 | CMS |
| ABBVIE INC. | $20.16 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105353846 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $13.68 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147006975 | CMS |
| Gilead Sciences, Inc. | $22.29 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133779398 | CMS |
| Gilead Sciences, Inc. | $22.54 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133779400 | CMS |
| Janssen Biotech, Inc. | $19.65 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078415420 | CMS |
| Janssen Biotech, Inc. | $14.25 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078415631 | CMS |
| Lilly USA, LLC | $16.25 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135437075 | CMS |
| Madrigal Pharmaceuticals | $22.23 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144179663 | CMS |
| Madrigal Pharmaceuticals | $25.33 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144179665 | CMS |
| PFIZER INC. | $19.14 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131157270 | CMS |
| QOL Medical, LLC | $20.09 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147724890 | CMS |
| QOL Medical, LLC | $21.26 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147724892 | CMS |
| Regeneron Healthcare Solutions, Inc. | $21.29 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114142375 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.14 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153482654 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.